A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS-NF1 Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Healthy

Interventions

DRUG

Pregabalin 150mg

GLA5PR GLARS-NF1 tablet 150mg/day(Pregabalin 150mg once a day)

DRUG

Pregabalin 75mg

Lyrica Capsule 150mg/day(Pregabalin 75mg twice a day)